Chemoinformaics analysis of (10E,12Z)-9-OXO-10,12-OCTADECADIENOIC-ACID
Molecular Weight | 294.435 | nRot | 14 |
Heavy Atom Molecular Weight | 264.195 | nRig | 4 |
Exact Molecular Weight | 294.219 | nRing | 0 |
Solubility: LogS | -3.529 | nHRing | 0 |
Solubility: LogP | 4.233 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 52.4698 |
nHD | 1 | BPOL | 31.8322 |
QED | 0.36 |
Synth | 2.574 |
Natural Product Likeliness | 1.576 |
NR-PPAR-gamma | 0.959 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.166 |
Pgp-sub | 0.002 |
HIA | 0.014 |
CACO-2 | -4.955 |
MDCK | 0.0000265 |
BBB | 0.316 |
PPB | 0.97032 |
VDSS | 0.351 |
FU | 0.0198212 |
CYP1A2-inh | 0.056 |
CYP1A2-sub | 0.44 |
CYP2c19-inh | 0.026 |
CYP2c19-sub | 0.262 |
CYP2c9-inh | 0.15 |
CYP2c9-sub | 0.986 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.487 |
CYP3a4-inh | 0.056 |
CYP3a4-sub | 0.046 |
CL | 1.786 |
T12 | 0.892 |
hERG | 0.06 |
Ames | 0.02 |
ROA | 0.196 |
SkinSen | 0.956 |
Carcinogencity | 0.634 |
EI | 0.647 |
Respiratory | 0.902 |
NR-Aromatase | 0.08 |
Antiviral | Yes |
Prediction | 0.547253 |